Andere talen MusclePharm Corporation

Aandelen

MSLP

US6273352012

Beurs gesloten - OTC Markets Andere beurzen 21:28:56 03-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,000001 ^USD	-99,92%		-.--%	-.--%

2023	Tweede motie voor verlenging exclusiviteitsperiode goedgekeurd voor MusclePharm Corporation	CI
2023	FitLife Brands, Inc. (NasdaqCM:FTLF) heeft de overname afgerond van vrijwel alle activa van MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18-10-23
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	10-10-23
Motion for Asset Sale Approved for MusclePharm Corporation	03-10-23
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	27-09-23
Stalking Horse Agreement Filed by MusclePharm Corporation	08-09-23
Musclepharm Corporation Announces Resignation of Paul Karr as Director	31-08-23
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28-08-23
First Amended Disclosure Statement Approved for MusclePharm Corporation	28-08-23
Bidding Procedure Approved for MusclePharm Corporation	17-08-23
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	19-07-23
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	28-06-23
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19-06-23
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26-05-23
Motion for Asset Sale Filed by MusclePharm Corporation	12-05-23
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10-05-23
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16-04-23
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	10-04-23
DIP Financing Approved for MusclePharm Corporation	08-03-23
Amended DIP Financing Approved for MusclePharm Corporation	23-01-23
Interim DIP Financing Approved for MusclePharm Corporation	09-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MusclePharm Corporation

Aandelen

MSLP

US6273352012

Andere talen

Filters